| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4cabb775ed8b2e3f4fe71aab411e4842 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2202-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-06 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61C8-0006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3691
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-362
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-284
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3625
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-0015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L89-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-0035
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-0041 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-46 |
| filingDate |
2018-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2022-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c8f3fc42acd9e6491b7f2893ee47865
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_396617094566d27de6a5877a5cb6be64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2aa30be72519d8496fa78bfd2fd09713 |
| publicationDate |
2022-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2897211-T3 |
| titleOfInvention |
Use of a Dry Implant Composition for the Preparation of an Injectable Aqueous Implant Formulation |
| abstract |
A dry implant composition consisting essentially of a mixture of natural bone-derived nanocrystalline hydroxyapatite particles 50 to 200 μm in size and fragments of a naturally cross-linked fibrous collagen material that pass through a 0.5 mm sieve , so the w/w ratio between nanocrystalline hydroxyapatite and collagen is 1.8 to 4.5. |
| priorityDate |
2017-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |